abstract |
The present invention relates to ligands having binding specificities for endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), VEGF and EGFR. The present invention also relates to the use of such ligands. In particular, it relates to the use of such ligands for the treatment of cancer. |